Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance

SIMPLE SUMMARY: Many patients with the aggressive cancer diffuse large B-cell lymphoma (DLBCL) still respond poorly to treatment and suffer from relapsed or refractory disease. The identification of gene mutations that are responsible for the outgrowth of the relapsed tumor is crucial to understand...

Descripción completa

Detalles Bibliográficos
Autores principales: Berendsen, Madeleine R., Stevens, Wendy B. C., van den Brand, Michiel, van Krieken, J. Han, Scheijen, Blanca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Ejemplares similares